There is exciting news out of the 2008 Genitourinary Cancers Symposium in San Francisco. An abstract (American Society of Clinical Oncology 2008 Genitourinary Cancers Symposium (GCS): Abstract 85) presented at the conference described a retrospective study that strongly suggests that salvage radiotherapy reduced the risk of dying from prostate cancer by more than 60% for [...]
Those of us in the prostate cancer world know that our disease presents us with many contradictions. Our dietary and suggested supplement recommendations seem to be modified as often as the wind changes direction. Even more serious is our lack of good tumor markers for disease progression. The result is we are forced to make [...]
This morning’s New York Times on-line carried an interesting story written by Gina Kolata about what could be the next wave of cancer research, cancerous stem cells (csc). Despite the common belief that cancerous cells can just continue to divide and divide forever, now some researchers believe that cancerous tumor cells are, just as normal [...]
Dr. Clinton T. Rubin, Ph.D., Distinguished Professor and Director for Center for Biotechnology at the State University of New York at Stony Brook, is reporting that mice placed on a platform that buzzes for 15 minutes a day, five days a week have 27 percent less fat than mice that did not stand on the [...]
Often, the FDA limits access to clinical trials to patients who have failed all other approved therapies. This means that we only evaluate potential new drugs on individuals who are already very sick and have been weakened by their disease as well as their prior treatments. Cancer cells "learn" how to survive treatments by mutating. [...]